ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition

December 2, 2025 11:34 AM EST Updated 04:04 PM FinancingStartupsDeals Ex­clu­sive: ARCH, Park­er In­sti­tute build next big on­col­o­gy bet with suite of pro­grams and start­up ac­qui­si­tion Kyle LaHucik Biotech Correspondent Some of the biggest names in on­col­o­gy R&D have been qui­et­ly con­sol­i­dat­ing as­sets, mon­ey and pro­grams un­der a new start­up called Medici Ther­a­peu­tics, End­points News … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER